Similarly, CUR has been found to inhibit cell viability, promote cell apoptosis, and arrest the cell cycle in the G2 phase of human DLBCL cells both in vitro and in vivo by upregulating the expression of PPARγ and deactivating the Akt/mTOR pathway [143]. The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.